To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbidities

Condition	Treatment or Intervention	Phase
Obesity Weight Loss	Drug: Rimonabant	Phase III

Further Study Details: 

Expected Total Enrollment:  2800

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

• Stable weight (variation of less than 5 kg within 3 months prior to screening visit)
• BMI (Body Mass Index) of 30 or greater in patients with or without comorbidities, or BMI greater than 27 in patients with treated or untreated hypertension and/or treated or untreated dyslipidemia

Alabama
      Radiant Research, Birmingham,  Alabama,  35209,  United States
Arizona
      Radiant Research, Phoenix,  Arizona,  85013,  United States
California
      Diablo Clinical Research, Inc., Walnut Creek,  California,  94598,  United States
      East Bay Clinical Trial Center, Concord,  California,  94520,  United States
      Scripps Clinic, San Diego,  California,  92130,  United States
      Feighner Research Institute, San Diego,  California,  92121,  United States
Colorado
      Longmont Medical Research Network, Longmont,  Colorado,  80501,  United States
      Ranch View Family Medicine, Highlands Ranch,  Colorado,  80130,  United States
Delaware
      Health Core, Inc., Newark,  Delaware,  19713,  United States
District of Columbia
      George Washington Univ. Wieght Mmgt Program, Washington,  District of Columbia,  20037,  United States
Florida
      Miami Research Associates, Miami,  Florida,  33173,  United States
      Anchor Research Center, Naples,  Florida,  34102,  United States
      Central Florida Clinical Solutions, Ocoee,  Florida,  34761,  United States
      Palm Beach Research Center, West Palm Beach,  Florida,  33409,  United States
      Orlando Clinical Research Center, Orlando,  Florida,  32806,  United States
Georgia
      Medical Dietetics, Inc., Atlanta,  Georgia,  30339,  United States
Illinois
      Springfield Diabetes and Endocrine Center, Springfield,  Illinois,  62704,  United States
Indiana
      Medical Research Consortium, Indianapolis,  Indiana,  46208,  United States
Kansas
      Wichita Clinic, PA, Wichita,  Kansas,  67208,  United States
Kentucky
      University of KY Internal Medicine, Lexington,  Kentucky,  40536-9841,  United States
Louisiana
      Pennington Center, Baton Rouge,  Louisiana,  70808,  United States
Massachusetts
      JM Clinical Trials, Inc., Swansea,  Massachusetts,  02777,  United States
Montana
      Montana Medical Research, LLC, Missoula,  Montana,  59804,  United States
New Hampshire
      Endocrinology and Diabetes Consultants, PC, Dover,  New Hampshire,  03820,  United States
New Jersey
      Radiant Research, Lawrenceville,  New Jersey,  08648,  United States
New Mexico
      Lovelace Scientific Resources, Albuquerque,  New Mexico,  87108,  United States
New York
      Central New York Clinical Research, Manlius,  New York,  13104,  United States
      St. Luke's Roosevelt Hospital Center, New York,  New York,  10025,  United States
      Comprehensive Weight Control Program, New York,  New York,  10021,  United States
North Carolina
      Center for Nutrition and Preventive Medicine, Charlotte,  North Carolina,  28207,  United States
      Multi-Specialty Research Associates of North Carolina, Raleigh,  North Carolina,  27609,  United States
Ohio
      Radiant Research, Columbus,  Ohio,  43212,  United States
      Lindner Clinical Trials Center, Cincinnati,  Ohio,  45219,  United States
      South Dayton Research Associates, Beavercreek,  Ohio,  45431,  United States
Oregon
      Radiant Research, Portland,  Oregon,  97201,  United States
Pennsylvania
      Radiant Research, Wyomissing,  Pennsylvania,  19610,  United States
      SFM Clinical Trials, Scotland,  Pennsylvania,  17254,  United States
Tennessee
      Clinical Research Associates, Inc, Nashville,  Tennessee,  37203,  United States
      ClinSearch, Chattanooga,  Tennessee,  37404,  United States
Texas
      Radiant Research, Austin,  Texas,  78758,  United States
      Dallas Diabetes and Endocrine Center, Dallas,  Texas,  75230,  United States
      nTouch Research, Houston,  Texas,  77024,  United States
      Quality Research, Inc., San Antonio,  Texas,  78209,  United States
Utah
      Advanced Clinical Research, Salt Lake City,  Utah,  84102,  United States
Virginia
      Commonwealth Clinical Research Specialists (CCRS), Richmond,  Virginia,  23226,  United States
Washington
      Rainer Clinical Research Center, Inc., Renton,  Washington,  98055-5704,  United States
Wisconsin
      Clinical Nutrition Clinic, University of Wisconsin, Madison,  Wisconsin,  53705,  United States
Canada, Ontario
      Group North, Windsor,  Ontario,  N8X3V6,  Canada
      Trial Management Group, Richmond Hill,  Ontario,  L4E3S8,  Canada
      Corunna Medical Clinic, Corunna,  Ontario,  N0N1G0,  Canada
      Quarry Family Medicine Clinic, Kingston,  Ontario,  K7L3E4,  Canada

Study ID Numbers:  EFC4743; SR141716
Record last reviewed:  November 2002
Last Updated:  October 13, 2004
Record first received:  January 23, 2002
ClinicalTrials.gov Identifier:  NCT00029861
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08